期刊文献+

全面、科学地评估胰岛素泵治疗的优势与临床获益 被引量:3

Scientific evaluation of the advantage and clinical benefits of continuous subcutaneous insulin infusion
下载PDF
导出
摘要 胰岛素泵治疗(CSII)弱化了胰岛素注射的不足,在提高患者血糖达标率、降低严重低血糖风险、减少远期并发症、改善患者生活质量方面具有显著优势,虽一次性投入费用较高,但从长远临床获益来看,具有显著优势。
出处 《药品评价》 CAS 2014年第9期40-44,共5页 Drug Evaluation
  • 相关文献

参考文献28

  • 1Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N EngI J Med, 2010; 362(12):1090-101. 被引量:1
  • 2中国医师协会内分泌代谢科医师分会,中华医学会内分泌学分会,中华医学会糖尿病学分会.中国胰岛素泵治疗指南,2010. 被引量:2
  • 3Pickup JC, Kidd J, Burmiston S, et al. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev, 2006,22(3):232-237. 被引量:1
  • 4Hoogma RP, Hammond PJ, Gomis R, et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med,2006;23(2):141-147. 被引量:1
  • 5Buse JB, Kudva YC, Battelino T, et al. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study. Diabetes Technol Ther, 2012, 14 (7): 644-647. 被引量:1
  • 6Lepore M, Pampanell S, Faneill C, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of Long-Acting Human Insulin Analog Glargine, NPH Insulin, and Ultralente Human Insulin and continuous subcutaneous infusion of Insulin Lispro. Diabetes,2000,49( 12):2142-2148. 被引量:1
  • 7Bulsara MK, Holman CD, Davis EA, et al. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population- based cohort of children with type 1 diabetes. Diabetes Care, 2004, 27(10): 2293-2298. 被引量:1
  • 8Boland EA, Grey M, Oesterle A, et al. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes, Diabetes Care, 1999,22( 11 ): 1779-1784. 被引量:1
  • 9Mozdzan M, Mozdzan M, Ruxer J, et al. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system. Adv Med Sci, 2006,51 : 133 - 136. 被引量:1
  • 10Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: recta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med, 2008, 25(7): 765-774. 被引量:1

二级参考文献8

  • 1刘娟,李延兵.早期胰岛素强化治疗在糖尿病治疗中的地位[J].新医学,2006,37(3):144-146. 被引量:34
  • 2刘兆川,王旭开,杨立,杨成明.外源性高胰岛素血症对血管内皮细胞sICAM-1表达的影响[J].第三军医大学学报,2006,28(9):936-938. 被引量:9
  • 3廖二元 超楚生.内分泌学[M].北京:人民卫生出版社,2001.610-611. 被引量:665
  • 4Lassmann-vague V,Guerci B,Hanaire-Broutin H.Insulin pumps (portable pump for subcutaneous perfusion of insulin)[J].Diabetes Metab,1995,21:373. 被引量:1
  • 5Mcmahon SK,Airey FL,Marangou DA,et al.Insulin pump therapy in children and adolescents:Improvements in key parameters of diabetes management including quality of life[J].Diabetic Med,2005,22(1):92-96. 被引量:1
  • 6Wilson DM,Buckingham BA,Kunselman EL,et al.A tow-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes[J].Diabetes Care,2005,28(1):15-19. 被引量:1
  • 7Feltbower RG,Campbell FM,Bodansky HJ,et al.Insulin pump therapy in childhood diabetes-Cost implications for primary care trusts[J].Diabetic Med,2006,23(1):86-89. 被引量:1
  • 8Roze S,Valentine WJ,Zakrzewgka KE,et al.Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of type 1 diabetes in the UK[J].Diabetic Med,2005,22(9):1239-1245. 被引量:1

共引文献22

同被引文献20

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部